Sonnet BioTherapeutics Holdings, Inc. Annual Depreciation in USD from 2011 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Sonnet BioTherapeutics Holdings, Inc. quarterly/annual Depreciation history and growth rate from 2011 to 2023.
  • Sonnet BioTherapeutics Holdings, Inc. Depreciation for the quarter ending December 31, 2023 was $3.21K, unchanged year-over-year.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2023 was $12.8K, unchanged from 2022.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2022 was $12.8K, a 3.12% increase from 2021.
  • Sonnet BioTherapeutics Holdings, Inc. annual Depreciation for 2021 was $12.5K, a 50.2% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.8K $0 0% Oct 1, 2022 Sep 30, 2023 10-K 2023-12-14
2022 $12.8K +$389 +3.12% Oct 1, 2021 Sep 30, 2022 10-K 2023-12-14
2021 $12.5K +$4.16K +50.2% Oct 1, 2020 Sep 30, 2021 10-K 2022-12-15
2020 $8.29K Oct 1, 2019 Sep 30, 2020 10-K 2021-12-17
2018 $1.64M -$307K -15.7% Jan 1, 2018 Dec 31, 2018 10-K 2019-04-01
2017 $1.95M Jan 1, 2017 Dec 31, 2017 10-K 2019-04-01
2013 $6.8K -$1.97K -22.5% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-31
2012 $8.77K -$65.5K -88.2% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-31
2011 $74.2K Jan 1, 2011 Dec 31, 2011 10-K 2013-04-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.